| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.72B | 2.74B | 1.98B | 3.60B | 1.86B | 1.92B |
| Gross Profit | 709.40M | 808.76M | 823.64M | 1.22B | 907.10M | 974.96M |
| EBITDA | -823.38M | -705.81M | -376.63M | 533.79M | 174.49M | 245.59M |
| Net Income | -1.36B | -922.43M | -753.85M | 12.78M | -305.23M | 123.88M |
Balance Sheet | ||||||
| Total Assets | 12.71B | 13.73B | 17.58B | 18.39B | 20.06B | 20.45B |
| Cash, Cash Equivalents and Short-Term Investments | 778.14M | 796.09M | 1.33B | 1.75B | 1.96B | 2.47B |
| Total Debt | 4.39B | 5.29B | 7.11B | 7.05B | 7.63B | 7.84B |
| Total Liabilities | 6.53B | 6.95B | 9.46B | 9.01B | 10.46B | 10.48B |
| Stockholders Equity | 4.03B | 4.33B | 5.27B | 5.92B | 5.99B | 6.44B |
Cash Flow | ||||||
| Free Cash Flow | 835.36M | 1.13B | -206.60M | 491.96M | -2.21B | -1.17B |
| Operating Cash Flow | 881.94M | 1.18B | -174.67M | 549.19M | -2.13B | -1.11B |
| Investing Cash Flow | -13.73M | 656.19M | 433.31M | 423.84M | 2.42B | 833.47M |
| Financing Cash Flow | -1.19B | -2.32B | -358.94M | -1.01B | -444.62M | 551.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | HK$1.04B | 19.78 | 3.24% | 2.00% | -54.92% | 26.32% | |
49 Neutral | HK$261.45M | -0.28 | -30.56% | ― | 30.86% | -67.89% | |
48 Neutral | HK$248.86M | -2.06 | -66.52% | ― | -92.58% | -44916.67% | |
45 Neutral | HK$135.47M | -2.52 | -18.50% | ― | -19.10% | 83.61% | |
41 Neutral | HK$575.00M | -1.61 | -4.03% | ― | 55.27% | 68.84% |
Wang On Group Limited has amended and restated the terms of reference for its nomination committee, effective 16 March 2026, to align with Hong Kong Listing Rules, the Corporate Governance Code and applicable laws. The revised framework formalises the committee’s membership mix, meeting procedures, authority to seek information and professional advice, and its mandate to regularly review the board’s structure, size, diversity and skills matrix, reinforcing the Group’s corporate governance and board effectiveness.
The nomination committee must comprise at least three directors with a majority of independent non-executive directors and at least one director of a different gender, and will be chaired by the board chairman or an independent non-executive director. By clarifying quorum, documentation standards, and its role in recommending board changes to support the Group’s strategy, the company strengthens transparency and oversight, which may enhance investor confidence and align the board’s composition more closely with long-term strategic needs.
The most recent analyst rating on (HK:1222) stock is a Hold with a HK$0.02 price target. To see the full list of analyst forecasts on Wang On Group Limited stock, see the HK:1222 Stock Forecast page.